Caption Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.2M Buy
71,600
+35,500
+98% +$19.3M 0.21% 101
2025
Q4
$20.9M Buy
+36,100
New +$20.4M 0.14% 163
2023
Q4
Sell
-15,000
Closed -$7.59M 1676
2023
Q3
$7.59M Buy
+15,000
New +$7.99M 0.12% 218
2023
Q1
Sell
-10,000
Closed -$5.51M 1554
2022
Q4
$5.51M Hold
10,000
0.09% 278
2022
Q3
$5.07M Hold
10,000
0.07% 347
2022
Q2
$5.43M Buy
+10,000
New +$5.5M 0.07% 322
2021
Q4
Sell
-20,000
Closed -$11.4M 1933
2021
Q3
$11.4M Buy
+20,000
New +$11M 0.13% 207

Other funds holding TMO

Caption Management's TMO Position: Q1 2026 in Review

Caption Management sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 8,000 shares — an estimated $4.34M sold.

Caption Management first reported a position in TMO in Q3 2021 and held it in 5 quarters. The position peaked at $5.14M in Q3 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Caption Management reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 8,000 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.34M.
  • Caption Management first reported a position in Thermo Fisher Scientific in Q3 2021 and held it in 5 quarters.
  • Caption Management's Thermo Fisher Scientific position peaked at $5.14M in Q3 2021.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.